AAAAAA

   
Results: 1-9 |
Results: 9
Immunoadjuvant activity of interferon-gamma-liposomes co-administered withinfluenza vaccines
Authors: van Slooten, ML Hayon, I Babai, I Zakay-Rones, Z Wagner, E Storm, G Kedar, E
Citation: Ml. Van Slooten et al., Immunoadjuvant activity of interferon-gamma-liposomes co-administered withinfluenza vaccines, BBA-MOL C B, 1531(1-2), 2001, pp. 99-110
A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity andrespiratory morbidity over the winter of 1997-98
Authors: Kiderman, A Furst, A Stewart, B Greenbaum, E Morag, A Zakay-Rones, Z
Citation: A. Kiderman et al., A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity andrespiratory morbidity over the winter of 1997-98, J CLIN VIRO, 20(3), 2001, pp. 155-161
Is herpes simplex virus associated with pulp/periapical inflammation?
Authors: Heling, I Morag-Hezroni, M Marva, E Hochman, N Zakay-Rones, Z Morag, A
Citation: I. Heling et al., Is herpes simplex virus associated with pulp/periapical inflammation?, ORAL SURG O, 91(3), 2001, pp. 359-361
A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains
Authors: Babai, I Barenholz, Y Zakay-Rones, Z Greenbaum, E Samira, S Hayon, I Rochman, M Kedar, E
Citation: I. Babai et al., A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains, VACCINE, 20(3-4), 2001, pp. 505-515
Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine
Authors: Greenbaum, E Furst, A Kiderman, A Stewart, B Levy, R Schlesinger, M Morag, A Zakay-Rones, Z
Citation: E. Greenbaum et al., Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine, J MED VIROL, 65(1), 2001, pp. 178-184
Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly
Authors: Muszkat, M Friedman, G Schein, MH Naveh, P Greenbaum, E Schlesinger, M Zakay-Rones, Z Ben Yehuda, A
Citation: M. Muszkat et al., Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly, VACCINE, 18(16), 2000, pp. 1696-1699
Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine
Authors: Muszkat, M Ben Yehuda, A Schein, MH Friedlander, Y Naveh, P Greenbaum, E Schlesinger, M Levy, R Zakay-Rones, Z Friedman, G
Citation: M. Muszkat et al., Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine, J MED VIROL, 61(1), 2000, pp. 100-106
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice
Authors: Babai, I Samira, S Barenholz, Y Zakay-Rones, Z Kedar, E
Citation: I. Babai et al., A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice, VACCINE, 17(9-10), 1999, pp. 1223-1238
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice
Authors: Babai, I Samira, S Barenholz, Y Zakay-Rones, Z Kedar, E
Citation: I. Babai et al., A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice, VACCINE, 17(9-10), 1999, pp. 1239-1250
Risultati: 1-9 |